Regen BioPharma Inc SEC filings RGBPP
Regen BioPharma Inc has 263 filings in SEC EDGAR's recent list, going back to Oct 15, 2013. Its latest annual report, Form 10-K, was filed on Dec 30, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Nov 2, 2026 | Oct 27, 2026 |
| 10-Q | Quarterly report | Aug 17, 2026 | Jun 30, 2026 |
| NT 10-Q | Filing | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Auditor change, Other events
|
Jul 15, 2026 | Jul 10, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Mar 4, 2026 | Feb 4, 2026 |
| 10-Q | Quarterly report | Feb 13, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Feb 2, 2026 | Jan 15, 2026 |
| 8-K |
Current report
Other events
|
Jan 21, 2026 | Jan 19, 2026 |
| QUALIF | Filing | Jan 12, 2026 | — |
| 1-A POS | Filing | Jan 8, 2026 | — |
| 10-K | Annual report | Dec 30, 2025 | Sep 30, 2025 |
| 253G1 | Filing | Dec 5, 2025 | — |
| QUALIF | Filing | Dec 3, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| 1-A | Filing | Nov 17, 2025 | — |
| 8-K |
Current report
Unregistered share sale
|
Nov 13, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 3, 2025 | Oct 2, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Sep 19, 2025 | Sep 15, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 12, 2025 | — |
| 253G1 | Filing | Sep 8, 2025 | — |
| QUALIF | Filing | Sep 5, 2025 | — |
| CORRESP | Letter to the SEC | Sep 4, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2025 | — |
| 1-A | Filing | Aug 29, 2025 | — |
| 1-A-W | Filing | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 7, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 1, 2025 | Jul 28, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jun 11, 2025 | Jun 10, 2025 |
| 15-15D/A | Filing | May 29, 2025 | — |
| 10-Q | Quarterly report | May 28, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | May 16, 2025 | Dec 31, 2024 |
| 10-K | Annual report | May 13, 2025 | Sep 30, 2024 |
| 8-K |
Current report
Restatement
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Auditor change
|
Apr 7, 2025 | Mar 31, 2025 |
| 1-A POS | Filing | Mar 3, 2025 | — |
| 253G1 | Filing | Feb 24, 2025 | — |
| 15-15D/A | Filing | Dec 31, 2024 | — |
| 15-15D | Filing | Dec 26, 2024 | — |
| QUALIF | Filing | Dec 10, 2024 | — |
| CORRESP | Letter to the SEC | Dec 9, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 29, 2024 | Sep 30, 2024 |
| CORRESP | Letter to the SEC | Nov 21, 2024 | — |
| 1-A/A | Filing | Nov 21, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2024 | — |
| 1-A/A | Filing | Oct 28, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 18, 2024 | Sep 18, 2024 |
| 1-A | Filing | Sep 16, 2024 | — |
| 8-K |
Current report
Material agreement
|
Sep 13, 2024 | Sep 4, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 424B3 | Prospectus | May 29, 2024 | — |
| 8-K |
Current report
Auditor change
|
May 29, 2024 | May 28, 2024 |
| 424B3 | Prospectus | May 23, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
May 23, 2024 | May 20, 2024 |
| 424B3 | Prospectus | May 10, 2024 | — |
| 8-K |
Current report
Auditor change
|
May 10, 2024 | May 10, 2024 |
| 424B3 | Prospectus | Apr 29, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 29, 2024 | Apr 26, 2024 |
| 424B3 | Prospectus | Apr 24, 2024 | — |
| 10-Q | Quarterly report | Apr 24, 2024 | Mar 31, 2024 |
| 424B3 | Prospectus | Feb 9, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 9, 2024 | Feb 7, 2024 |
| 424B3 | Prospectus | Jan 19, 2024 | — |
| 10-Q | Quarterly report | Jan 19, 2024 | Dec 31, 2023 |
| 424B3 | Prospectus | Nov 20, 2023 | — |
| 10-K | Annual report | Nov 20, 2023 | Sep 30, 2023 |
| 424B3 | Prospectus | Oct 2, 2023 | — |
| EFFECT | Filing | Sep 29, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| S-1 | Registration statement | Sep 25, 2023 | — |
| 8-K |
Current report
Material agreement
|
Sep 18, 2023 | Sep 12, 2023 |
| 10-Q | Quarterly report | Jul 25, 2023 | Jun 30, 2023 |
| RW | Filing | Jul 24, 2023 | — |
| 424B3 | Prospectus | May 15, 2023 | — |
| EFFECT | Filing | May 12, 2023 | — |
| CORRESP | Letter to the SEC | May 11, 2023 | — |
| CORRESP | Letter to the SEC | May 2, 2023 | — |
| S-1/A | Amended registration statement | May 2, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2023 | — |
| 10-Q | Quarterly report | Apr 18, 2023 | Mar 31, 2023 |
| S-1 | Registration statement | Apr 13, 2023 | — |
| 8-K |
Current report
Unregistered share sale, Change to shareholder rights
|
Mar 21, 2023 | Mar 17, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 7, 2023 | Feb 6, 2023 |
| 10-Q | Quarterly report | Jan 19, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Unregistered share sale
|
Nov 21, 2022 | Nov 18, 2022 |
| 8-K |
Current report
Unregistered share sale
|
Nov 18, 2022 | Nov 11, 2022 |
| 10-K | Annual report | Nov 15, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 14, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Other events
|
Sep 20, 2022 | Sep 19, 2022 |
| 8-K |
Current report
Other events
|
Aug 10, 2022 | Aug 9, 2022 |
| 10-Q | Quarterly report | Jul 22, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Unregistered share sale
|
Jul 20, 2022 | Jul 19, 2022 |
| 8-K |
Current report
Unregistered share sale, Other events
|
May 17, 2022 | May 10, 2022 |
| 10-Q | Quarterly report | Apr 21, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 18, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Other events
|
Feb 18, 2022 | Feb 18, 2022 |
| 10-Q | Quarterly report | Jan 20, 2022 | Dec 31, 2021 |
| 8-K |
Current report
New debt
|
Jan 14, 2022 | Jan 13, 2022 |
| 10-K | Annual report | Dec 22, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Restatement
|
Dec 22, 2021 | Dec 17, 2021 |
| 10-Q/A | Amended quarterly report | Dec 22, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Other events
|
Dec 20, 2021 | Dec 13, 2021 |
| 8-K |
Current report
Other events
|
Nov 12, 2021 | Nov 11, 2021 |
| 8-K |
Current report
Other events
|
Nov 5, 2021 | Oct 12, 2021 |
| 8-K |
Current report
Other events
|
Nov 4, 2021 | Oct 12, 2021 |
| 8-K |
Current report
Other events
|
Oct 22, 2021 | Oct 22, 2021 |
| 8-K |
Current report
Material agreement
|
Oct 19, 2021 | Oct 18, 2021 |
| 8-K |
Current report
Other events
|
Sep 27, 2021 | Sep 23, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 24, 2021 | Sep 17, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 16, 2021 | Sep 15, 2021 |
| 8-K/A |
Amended current report
Other events
|
Aug 31, 2021 | Aug 27, 2021 |
| 8-K |
Current report
Other events
|
Aug 31, 2021 | Aug 27, 2021 |
| 10-Q | Quarterly report | Aug 27, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Other events
|
Aug 26, 2021 | Aug 17, 2021 |
| 10-Q | Quarterly report | Aug 18, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Aug 13, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2020 |
| 10-Q | Quarterly report | Aug 5, 2021 | Mar 31, 2020 |
| 10-Q | Quarterly report | Aug 5, 2021 | Dec 31, 2019 |
| 10-K | Annual report | Aug 4, 2021 | Sep 30, 2020 |
| 8-K |
Current report
Other events
|
Jul 14, 2021 | Jul 8, 2021 |
| 8-K |
Current report
Other events
|
Jul 13, 2021 | Jul 13, 2021 |
| 8-K |
Current report
Other events
|
Jul 2, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Other events
|
Jun 30, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Other events
|
Jun 28, 2021 | Jun 28, 2021 |
| 10-K | Annual report | Jun 21, 2021 | Sep 30, 2019 |
| 8-K |
Current report
Other events
|
Jun 1, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Other events
|
May 13, 2021 | May 12, 2021 |
| 8-K |
Current report
Other events
|
May 7, 2021 | May 7, 2021 |
| 8-K |
Current report
Unregistered share sale, Change to shareholder rights
|
Apr 27, 2021 | Apr 23, 2021 |
| 8-K |
Current report
Other events
|
Apr 21, 2021 | Apr 21, 2021 |
| 8-K |
Current report
Other events
|
Apr 19, 2021 | Apr 19, 2021 |
| 8-K |
Current report
Material agreement
|
Apr 16, 2021 | Apr 15, 2021 |
| 8-K |
Current report
Other events
|
Apr 9, 2021 | Apr 8, 2021 |
| 8-K |
Current report
Material agreement
|
Apr 8, 2021 | Apr 7, 2021 |
| 8-K |
Current report
Other events
|
Mar 30, 2021 | Mar 26, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2021 | Mar 23, 2021 |
| SC 13G | Ownership over 5% (passive) | Mar 3, 2020 | — |
| 8-K |
Current report
Agreement ended, Officer or director change
|
Jan 22, 2020 | Jan 20, 2020 |
| 8-K |
Current report
Other events
|
Jan 7, 2020 | Dec 13, 2019 |
| 8-K | Current report | Dec 18, 2019 | Dec 16, 2019 |
| 8-K |
Current report
Officer or director change
|
Nov 18, 2019 | Nov 18, 2019 |
| 10-Q | Quarterly report | Oct 24, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | Aug 29, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Other events
|
Aug 14, 2019 | Aug 14, 2019 |
| 8-K |
Current report
Other events
|
Aug 14, 2019 | Aug 13, 2019 |
| 8-K |
Current report
Other events
|
Aug 13, 2019 | Aug 13, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 29, 2019 | Jul 19, 2019 |
| 8-K |
Current report
Auditor change
|
Jul 29, 2019 | Jul 24, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Jul 2, 2019 | Jun 27, 2019 |
| NT 10-Q/A | Filing | May 24, 2019 | Mar 31, 2019 |
| NT 10-Q | Form nt 10-q | May 14, 2019 | Mar 31, 2019 |
| 8-K/A |
Amended current report
Regulation FD disclosure, Other events
|
May 10, 2019 | May 8, 2019 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 8, 2019 | May 8, 2019 |
| 8-K |
Current report
Auditor change
|
Apr 10, 2019 | Apr 8, 2019 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 15, 2019 | Mar 13, 2019 |
| 8-K |
Current report
Other events
|
Feb 19, 2019 | Feb 13, 2019 |
| 10-Q | Quarterly report | Feb 12, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Officer or director change
|
Jan 25, 2019 | Jan 22, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 11, 2019 | Jan 10, 2018 |
| 10-K | Annual report | Dec 27, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Nov 20, 2018 | Nov 15, 2018 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 12, 2018 | Oct 11, 2018 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 4, 2018 | Oct 2, 2018 |
| 8-K |
Current report
Unregistered share sale
|
Oct 4, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 6, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Other events
|
Jul 6, 2018 | Jul 3, 2018 |
| 10-Q | Quarterly report | May 14, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Feb 6, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Jan 5, 2018 | Sep 30, 2017 |
| NT 10-K | Form nt 10-k | Dec 28, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 7, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | May 5, 2017 | Mar 31, 2017 |
| UPLOAD | Letter from the SEC | May 2, 2017 | — |
| CORRESP | Letter to the SEC | Apr 28, 2017 | — |
| 10-Q/A | Amended quarterly report | Apr 28, 2017 | Dec 31, 2016 |
| 10-K/A | Amended annual report | Apr 28, 2017 | Sep 30, 2016 |
| 10-Q/A | Amended quarterly report | Apr 28, 2017 | Jun 30, 2016 |
| 10-Q/A | Amended quarterly report | Apr 28, 2017 | Mar 31, 2016 |
| 10-Q/A | Amended quarterly report | Apr 28, 2017 | Dec 31, 2015 |
| 10-K/A | Amended annual report | Apr 28, 2017 | Sep 30, 2015 |
| 10-Q/A | Amended quarterly report | Apr 28, 2017 | Jun 30, 2015 |
| 10-Q/A | Amended quarterly report | Apr 28, 2017 | Mar 31, 2015 |
| 8-K |
Current report
Restatement
|
Mar 31, 2017 | Mar 30, 2017 |
| CORRESP | Letter to the SEC | Mar 30, 2017 | — |
| 10-Q/A | Amended quarterly report | Mar 30, 2017 | Dec 31, 2016 |
| 10-K/A | Amended annual report | Mar 30, 2017 | Sep 30, 2016 |
| 10-Q/A | Amended quarterly report | Mar 30, 2017 | Jun 30, 2016 |
| 10-Q/A | Amended quarterly report | Mar 30, 2017 | Mar 31, 2016 |
| 10-Q/A | Amended quarterly report | Mar 30, 2017 | Dec 31, 2015 |
| 10-K/A | Amended annual report | Mar 30, 2017 | Sep 30, 2015 |
| 10-Q/A | Amended quarterly report | Mar 30, 2017 | Jun 30, 2015 |
| 10-Q/A | Amended quarterly report | Mar 30, 2017 | Mar 31, 2015 |
| CORRESP | Letter to the SEC | Mar 22, 2017 | — |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Other events
|
Mar 14, 2017 | Mar 14, 2017 |
| UPLOAD | Letter from the SEC | Mar 9, 2017 | — |
| 8-K |
Current report
Material agreement
|
Feb 9, 2017 | Feb 9, 2017 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RGBP (OTC), RGBPP (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- La Mesa, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1589150
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.